Methotrexate treatment in patients with a history of cutaneous melanoma and the risk of a consecutive primary melanoma: A national retrospective registry-based.

Slides:

Advertisements

Similar presentations

Surgical margins for melanoma in situ

Advertisements

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

A population-based cohort study of the influence of socioeconomic factors and race on survival in Merkel cell carcinoma Reshmi Madankumar, MD, Maressa.

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

Striking leflunomide efficacy against refractory cutaneous sarcoidosis

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD

Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD

Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery

Baldness reversed by chemotherapy

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD

Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B- cell lymphomas: A retrospective study Amrita Goyal, MD, Joi B.

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma

María Jesús Suárez Valladares, MD, Manuel Ángel Rodríguez Prieto, MD

Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002 Irwin B. Horwitz, PhD, Brian P. McCall,

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Pediatric teledermatology: Observations based on 429 consults

Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort Shelley.

Diameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: A case-control study Michael Y.

Assessing adherence with phototherapy protocols

Malignancy-associated dermatomyositis: Retrospective case–control study from a single tertiary care center Laura Kooistra, BS, Claudia Ricotti, BS, Fabrizio.

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Smoking and risk of psoriasis: A nationwide cohort study

Applying for dermatology residency is difficult and expensive

The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity–United States, 2000 to 2006 Donatus U. Ekwueme, MS, PhD, Gery.

The Africa Teledermatology Project: Preliminary experience with a sub-Saharan teledermatology and e-learning program Steven Kaddu, MD, H. Peter Soyer,

Characterization of disease burden, comorbidities, and treatment use in a large, US- based cohort: Results from the Corrona Psoriasis Registry Bruce Strober,

Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P

Alopecia areata Journal of the American Academy of Dermatology

Google search trends for tanning salons: Temporal patterns indicate peak interest in mid spring Derek D. Reed, PhD, BCBA-D Journal of the American Academy.

The applicability and prognostic value of the TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome.

A population-based cohort study of the influence of socioeconomic factors and race on survival in Merkel cell carcinoma Reshmi Madankumar, MD, Maressa.

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Fever, eosinophilia, and a rash

Infectious rash after riding elephants

Lip edema Journal of the American Academy of Dermatology

Adult-onset multiple myofibromas

Solomon Shockman, MD, Lauren Krug, MD, Nektarios Lountzis, MD

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Leflunomide as adjuvant treatment of dermatomyositis

Pooja H. Rambhia, BA, Ivan J. Stojanov, DMD, Joshua Arbesman, MD

Hugh Gloster, MD, Chesahna Kindred, MBA

Seasonal patterns in alopecia areata, totalis, and universalis

Appearance of lentigines in psoriasis patients treated with apremilast

Medicaid acceptance among pediatric dermatologists

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients? Michael A. Marchetti, MD, Edmund K. Bartlett,

Recent dermatology visit is associated with thinner Breslow depth nodular melanomas Erin X. Wei, MD, Lucy Chen, MD, Fangchao Ma, PhD, Jonette Keri, MD,

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Hyun Sun Jeon, MD, Mira Choi, MD, Seong Jun Byun, MS, Leejee H

Modification of the nail psoriasis severity index

Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry Ulrike.

Tofacitinib therapy for children with severe alopecia areata

Gordon W. Jung, MD, Patricia T. Ting, MSc, MD, Thomas G

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation Suelen Montagner, MD, Francisco Aparecido.

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

Eyebrow transplantation: Alternative body sites as a donor source

Gaps in pain management in dermatology: A needs assessment from Canada

Sirolimus for treatment of verrucous venous malformation: A retrospective cohort study Gaolei Zhang, MD, PhD, Hongguang Chen, MD, PhD, Zhen Zhen, MD,

Numerous hyperpigmented macules of the oral mucosa

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Orit Kaidar-Person, MD, Ayelet Eran, MD, Gil Bar-Sela, MD

The JAAD adopts the CONSORT statement

Reporting of harm and safety results in randomized controlled trials published in 5 dermatology journals Cynthia Haddad, PharmD, MSc, Odette Berline.

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Presentation transcript:

Methotrexate treatment in patients with a history of cutaneous melanoma and the risk of a consecutive primary melanoma: A national retrospective registry-based cohort study Sam Polesie, MD, Martin Gillstedt, MSc, John Paoli, MD, PhD, Amra Osmancevic, MD, PhD Journal of the American Academy of Dermatology Volume 77, Issue 1, Pages 161-163 (July 2017) DOI: 10.1016/j.jaad.2017.02.032 Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Kaplan–Meier estimates for the proportion of patients that did not develop a second cutaneous melanoma (CMM) in the methotrexate (MTX)-exposed and MTX-unexposed groups. The number of patients at risk in the respective groups is specified at 0, 15, 30, and 45 years after the first reported CMM. The data include both in situ and invasive melanomas. The observation period constituted the time from the first CMM diagnosis to whichever came first: the end of the study period (December 31, 2014), death, or the diagnosis of a consecutive primary CMM. Local recurrence of a melanoma was not included as a consecutive primary CMM. Journal of the American Academy of Dermatology 2017 77, 161-163DOI: (10.1016/j.jaad.2017.02.032) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions